Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
glaxosmithkline
7
×
life sciences
national blog main
national top stories
san diego blog main
7
×
san diego top stories
san francisco blog main
startups
7
×
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
clinical trials
deals
alzheimer's disease
amgen
cancer
cancer immunotherapy
eli lilly
fda
merck
abbvie
biogen
What
roundup
bio
black
companies
crispr
diamond’s
drug
nash
news
according
acquire
acquisition
acquisitions
akcea
albert
alliance
appetite
approval
biggest
biogen’s
biopharmaceutical
biotech
boosts
bourla
bread
bristol
butter
buy
buyout
calls
cancer
cases
cash
centers
ceo
changing
cigarettes
color
company
connected
Language
unset
unknown
Current search:
glaxosmithkline
×
startups
×
" san diego blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
ResMed Boosts Connected Health Play With $225M Propeller Health Deal
